Can [18F]Fluorodeoxyglucose Positron Emission Tomography Replace Bone Marrow Biopsy in Staging of Malignant Lymphoma?
- 20 September 2004
- journal article
- other
- Published by Elsevier in Clinical Lymphoma
- Vol. 5 (2) , 127
- https://doi.org/10.1016/s1526-9655(11)70068-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Enhanced Marrow [18F]Fluorodeoxyglucose Uptake Related to Myeloid Hyperplasia in Hodgkin's Lymphoma Can Simulate Lymphoma Involvement in MarrowClinical Lymphoma, 2004
- Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphomaBritish Journal of Cancer, 2004
- Pain Perception in Patients Undergoing Bone Marrow Puncture—A Pilot StudyPerceptual and Motor Skills, 2004
- Diffuse Bone Marrow Involvement of Hodgkin Lymphoma Mimics Hematopoietic Cytokine-Mediated FDG uptake on FDG PET ImagingClinical Nuclear Medicine, 2003
- Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma.Clinical Lymphoma, 2003
- Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission TomographyClinical Lymphoma, 2001
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission TomographyBlood, 1998
- 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.Journal of Clinical Oncology, 1998
- Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.Journal of Clinical Oncology, 1998
- Bilateral Trephine Bone Marrow Biopsies in Lymphoma and Other Neoplastic DiseasesAnnals of Internal Medicine, 1975